TRIM21 mediates the degradation of the autophagic lysosomal pathway of cyclin-dependent kinase 2 (CDK2) to inhibit the proliferation of acute myeloid leukemia [57]. This evidence concerns the gene TRIM21 and acute myeloid leukemia.